BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36567534)

  • 1. Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry.
    Wei J; Beebe-Dimmer J; Shi Z; Sample C; Yan G; Rifkin AS; Sadeghpour A; Gielzak M; Choi S; Moon D; Zheng SL; Helfand BT; Walsh PC; Xu J; Cooney KA; Isaacs WB
    Prostate; 2023 Apr; 83(5):454-461. PubMed ID: 36567534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients.
    Na R; Wei J; Sample CJ; Gielzak M; Choi S; Cooney KA; Rabizadeh D; Walsh PC; Zheng LS; Xu J; Isaacs WB
    Br J Cancer; 2022 Mar; 126(5):791-796. PubMed ID: 34799695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.
    Darst BF; Wan P; Sheng X; Bensen JT; Ingles SA; Rybicki BA; Nemesure B; John EM; Fowke JH; Stevens VL; Berndt SI; Huff CD; Strom SS; Park JY; Zheng W; Ostrander EA; Walsh PC; Srivastava S; Carpten J; Sellers TA; Yamoah K; Murphy AB; Sanderson M; Crawford DC; Gapstur SM; Bush WS; Aldrich MC; Cussenot O; Yeager M; Petrovics G; Cullen J; Neslund-Dudas C; Kittles RA; Xu J; Stern MC; Kote-Jarai Z; Govindasami K; Chokkalingam AP; Multigner L; Parent ME; Menegaux F; Cancel-Tassin G; Kibel AS; Klein EA; Goodman PJ; Drake BF; Hu JJ; Clark PE; Blanchet P; Casey G; Hennis AJM; Lubwama A; Thompson IM; Leach R; Gundell SM; Pooler L; Xia L; Mohler JL; Fontham ETH; Smith GJ; Taylor JA; Eeles RA; Brureau L; Chanock SJ; Watya S; Stanford JL; Mandal D; Isaacs WB; Cooney K; Blot WJ; Conti DV; Haiman CA
    Eur Urol; 2020 Sep; 78(3):316-320. PubMed ID: 32409115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
    Giri VN; Hartman R; Pritzlaff M; Horton C; Keith SW
    JCO Precis Oncol; 2022 May; 6(1):e2200234. PubMed ID: 35666082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic ancestry and prostate cancer susceptibility SNPs in Puerto Rican and African American men.
    Irizarry-Ramírez M; Kittles RA; Wang X; Salgado-Montilla J; Nogueras-González GM; Sánchez-Ortiz R; Guerrios L; Rivera K; Shah E; Prokhorova I; Roberson P; Troncoso P; Pettaway CA
    Prostate; 2017 Jul; 77(10):1118-1127. PubMed ID: 28543179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry.
    White JA; Kaninjing ET; Adeniji KA; Jibrin P; Obafunwa JO; Ogo CN; Mohammed F; Popoola A; Fatiregun OA; Oluwole OP; Karanam B; Elhussin I; Ambs S; Tang W; Davis M; Polak P; Campbell MJ; Brignole KR; Rotimi SO; Dean-Colomb W; Odedina FT; Martin DN; Yates C
    Cancer Res Commun; 2022 Sep; 2(9):1005-1016. PubMed ID: 36922933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.
    Kittles RA; Baffoe-Bonnie AB; Moses TY; Robbins CM; Ahaghotu C; Huusko P; Pettaway C; Vijayakumar S; Bennett J; Hoke G; Mason T; Weinrich S; Trent JM; Collins FS; Mousses S; Bailey-Wilson J; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD
    J Med Genet; 2006 Jun; 43(6):507-11. PubMed ID: 16155194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
    Chandrasekar T; Gross L; Gomella LG; Hegarty SE; Leong JY; Giri VN
    Eur Urol Oncol; 2020 Jun; 3(3):291-297. PubMed ID: 31278035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression.
    Xu J; Shi Z; Wei J; Na R; Resurreccion WK; Wang CH; Sample C; Han M; Zheng SL; Cooney KA; Helfand BT; Isaacs WB
    Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):749-754. PubMed ID: 35149774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutations in PPFIBP2 are associated with lethal prostate cancer.
    Wu Y; Yu H; Zheng SL; Feng B; Kapron AL; Na R; Boyle JL; Shah S; Shi Z; Ewing CM; Wiley KE; Luo J; Walsh PC; Carter HB; Helfand BT; Cooney KA; Xu J; Isaacs WB
    Prostate; 2018 Dec; 78(16):1222-1228. PubMed ID: 30043417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.
    Wu Y; Yu H; Zheng SL; Na R; Mamawala M; Landis T; Wiley K; Petkewicz J; Shah S; Shi Z; Novakovic K; McGuire M; Brendler CB; Ding Q; Helfand BT; Carter HB; Cooney KA; Isaacs WB; Xu J
    Prostate; 2018 Jun; 78(8):607-615. PubMed ID: 29520813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population.
    Petrovics G; Price DK; Lou H; Chen Y; Garland L; Bass S; Jones K; Kohaar I; Ali A; Ravindranath L; Young D; Cullen J; Dorsey TH; Sesterhenn IA; Brassell SA; Rosner IL; Ross D; Dahut W; Ambs S; Figg WD; Srivastava S; Dean M
    Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):406-410. PubMed ID: 30542053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.
    Chen F; Madduri RK; Rodriguez AA; Darst BF; Chou A; Sheng X; Wang A; Shen J; Saunders EJ; Rhie SK; Bensen JT; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Stanford JL; Zheng W; Sanderson M; John EM; Park JY; Xu J; Wang Y; Berndt SI; Huff CD; Yeboah ED; Tettey Y; Lachance J; Tang W; Rentsch CT; Cho K; Mcmahon BH; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Sellers TA; Yamoah K; Murphy AB; Crawford DC; Patel AV; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas CM; Stern MC; Kote-Jarai Z; Govindasami K; Cook MB; Chokkalingam AP; Hsing AW; Goodman PJ; Hoffmann TJ; Drake BF; Hu JJ; Keaton JM; Hellwege JN; Clark PE; Jalloh M; Gueye SM; Niang L; Ogunbiyi O; Idowu MO; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Diop H; Van Den Eeden SK; Blanchet P; Fowke JH; Casey G; Hennis AJ; Lubwama A; Thompson IM; Leach R; Easton DF; Preuss MH; Loos RJ; Gundell SM; Wan P; Mohler JL; Fontham ET; Smith GJ; Taylor JA; Srivastava S; Eeles RA; Carpten JD; Kibel AS; Multigner L; Parent MÉ; Menegaux F; Cancel-Tassin G; Klein EA; Andrews C; Rebbeck TR; Brureau L; Ambs S; Edwards TL; Watya S; Chanock SJ; Witte JS; Blot WJ; Michael Gaziano J; Justice AC; Conti DV; Haiman CA
    Eur Urol; 2023 Jul; 84(1):13-21. PubMed ID: 36872133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
    Ledet EM; Burgess EF; Sokolova AO; Jaeger EB; Hatton W; Moses M; Miller P; Cotogno P; Layton J; Barata P; Lewis BE; Nakazawa M; Zhu J; Dellinger B; Elrefai S; Nafissi NN; Egan JB; Shore N; McKay RR; Bryce AH; Cheng HH; Antonarakis ES; Sartor O
    Prostate; 2021 May; 81(7):433-439. PubMed ID: 33792945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.
    Darst BF; Hughley R; Pfennig A; Hazra U; Fan C; Wan P; Sheng X; Xia L; Andrews C; Chen F; Berndt SI; Kote-Jarai Z; Govindasami K; Bensen JT; Ingles SA; Rybicki BA; Nemesure B; John EM; Fowke JH; Huff CD; Strom SS; Isaacs WB; Park JY; Zheng W; Ostrander EA; Walsh PC; Carpten J; Sellers TA; Yamoah K; Murphy AB; Sanderson M; Crawford DC; Gapstur SM; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas C; Kittles RA; Xu J; Stern MC; Chokkalingam AP; Multigner L; Parent ME; Menegaux F; Cancel-Tassin G; Kibel AS; Klein EA; Goodman PJ; Stanford JL; Drake BF; Hu JJ; Clark PE; Blanchet P; Casey G; Hennis AJM; Lubwama A; Thompson IM; Leach RJ; Gundell SM; Pooler L; Mohler JL; Fontham ETH; Smith GJ; Taylor JA; Brureau L; Blot WJ; Biritwum R; Tay E; Truelove A; Niwa S; Tettey Y; Varma R; McKean-Cowdin R; Torres M; Jalloh M; Magueye Gueye S; Niang L; Ogunbiyi O; Oladimeji Idowu M; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Yeboah ED; Mensah JE; Anthony Adjei A; Diop H; Cook MB; Chanock SJ; Watya S; Eeles RA; Chiang CWK; Lachance J; Rebbeck TR; Conti DV; Haiman CA
    Eur Urol; 2022 May; 81(5):458-462. PubMed ID: 35031163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of prostate cancer in African-American men: Evidence of mixed effects of dietary quercetin by serum vitamin D status.
    Paller CJ; Kanaan YM; Beyene DA; Naab TJ; Copeland RL; Tsai HL; Kanarek NF; Hudson TS
    Prostate; 2015 Sep; 75(13):1376-83. PubMed ID: 26047130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
    Na R; Zheng SL; Han M; Yu H; Jiang D; Shah S; Ewing CM; Zhang L; Novakovic K; Petkewicz J; Gulukota K; Helseth DL; Quinn M; Humphries E; Wiley KE; Isaacs SD; Wu Y; Liu X; Zhang N; Wang CH; Khandekar J; Hulick PJ; Shevrin DH; Cooney KA; Shen Z; Partin AW; Carter HB; Carducci MA; Eisenberger MA; Denmeade SR; McGuire M; Walsh PC; Helfand BT; Brendler CB; Ding Q; Xu J; Isaacs WB
    Eur Urol; 2017 May; 71(5):740-747. PubMed ID: 27989354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry.
    Hurst Z; Liyanarachchi S; He H; Brock P; Sipos J; Nabhan F; Kebebew E; Green P; Cote GJ; Sherman S; Walker CJ; Chang YS; Xue S; Hollingsworth B; Li W; Genutis L; Menq E; de la Chapelle A; Jhiang SM
    Thyroid; 2019 Apr; 29(4):530-539. PubMed ID: 30654714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel.
    Leongamornlert DA; Saunders EJ; Wakerell S; Whitmore I; Dadaev T; Cieza-Borrella C; Benafif S; Brook MN; Donovan JL; Hamdy FC; Neal DE; Muir K; Govindasami K; Conti DV; Kote-Jarai Z; Eeles RA
    Eur Urol; 2019 Sep; 76(3):329-337. PubMed ID: 30777372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy.
    Tosoian JJ; Almutairi F; Morais CL; Glavaris S; Hicks J; Sundi D; Humphreys E; Han M; De Marzo AM; Ross AE; Tomlins SA; Schaeffer EM; Trock BJ; Lotan TL
    Eur Urol; 2017 May; 71(5):697-700. PubMed ID: 27477529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.